News Quantified

VNDA – vanda pharmaceuticals inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA

Vanda Pharmaceuticals Says FDA Rejects Hetlioz as Jet Lag Treatment [Yahoo! Finance]

Vanda Pharmaceuticals Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder

Assessing Vanda Pharmaceuticals (VNDA) Valuation After FDA Approval Of NEREUS For Motion Sickness [Yahoo! Finance]

Vanda Pharmaceuticals (NASDAQ:VNDA) had its "buy" rating reaffirmed by analysts at HC Wainwright.

-20.1%

MISS

-5.3%

MISS

-3.7%

BEAT

-6.0%

BEAT

Form SCHEDULE 13G/A Vanda Pharmaceuticals Filed by: MILLENNIUM MANAGEMENT LLC

Form 8-K Vanda Pharmaceuticals For: Jan 07

Form 8-K Vanda Pharmaceuticals For: Dec 30

Form 8-K Vanda Pharmaceuticals For: Dec 04

Form 8-K Vanda Pharmaceuticals For: Nov 28

Top News Gainers

7/31 Q2/2019 6/30/2019 EPS 0.280 ZacksConsensus -0.030 ActVsEst 0.310 - Beat 26.8%

4/2 Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 14.1%

11/6 Q3/2019 9/30/2019 EPS 1.880 ZacksConsensus 0.070 ActVsEst 1.810 - Beat 10.6%

8/19 FDA rejects Vanda's Hetlioz for jet lag disorder [Seeking Alpha] 8.9%

3/24 Form 3 Vanda Pharmaceuticals For: Mar 15 Filed by: Moran Kevin Patrick 7.3%

4/15 Vanda Pharmaceuticals Announces Initiation of "CALYPSO" to Study the Role of Genetic Variation in COVID-19 Infections in Collaboration With University of Washington Medicine 6.9%

2/25 Vanda Pharmaceuticals' (VNDA) CEO Mihales Polymeropoulos on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 6.8%

9/10 Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 6.2%

2/14 Form SC 13G/A Vanda Pharmaceuticals Filed by: Consonance Capital Management LP 5.3%

2/28 Form 4 Vanda Pharmaceuticals For: Feb 26 Filed by: Birznieks Gunther 3.9%

Top News Decliners

3/13 Form 8-K Vanda Pharmaceuticals For: Mar 12 -20.9%

11/7 Form 10-Q Vanda Pharmaceuticals For: Sep 30 -11.9%

2/20 Form 8-K Vanda Pharmaceuticals For: Feb 18 -9.1%

7/24 Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $17.00 price target on the stock. -7.0%

4/15 Vanda Pharmaceuticals, Northwell Health Conduct ODYSSEY Trial In Patients With Severe COVID-19 Pneumonia -6.2%

1/11 Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $19.00 price target on the stock. -5.6%

2/26 Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -5.4%

4/10 Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $12.00 price target on the stock. -4.7%

3/23 Florida man with coronavirus claims anti-malarial drug saved his life [FOX News] -4.5%

7/22 Vanda Pharmaceuticals FDA Update for HETLIOZ® in the Treatment of Jet Lag Disorder -4.5%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day